ACHL

AS OF

Mar 20 closing price

Price

$1.48

Change

+$0.01 (+0.68%)

Capitalization

63.22M

24 days until earnings call

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

ACHL Stock ACHL is expected to report earnings to rise+21% to -38 cents per share on March 24

GET DAILY SIGNALS

Get AI intraday signals

A.I.dvisor
at Tickeron.com

Buy or Sell

View Daily Signals

ACHL - Achilles Therapeutics plc

Achilles Therapeutics plc Earnings Graph

Q4'24

Est.

$-0.38

Q3'24

Missed

by $0.07

Q2'24

Est.

$-0.41

Q1'24

Beat

by $0.16

Q4'23

Missed

by $0.31

The last earnings report on September 30 showed earnings per share of -48 cents, missing the estimate of -41 cents. P/B Ratio (0.590) is normal, around the industry mean (13.470). P/E Ratio (0.000) is within average values for comparable stocks, (65.620). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.798). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (238.014). With 1.20M shares outstanding, the current market capitalization sits at 63.22M.

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

245 Hammersmith Road

Phone

+44 2081544600

Employees

242

Web

https://www.achillestx.com